Texas InstrumentsTPS79930YZUTLinear Regulators

LDO Regulator Pos 3V 0.2A 5-Pin DSBGA T/R

Make a theoretical system actual by providing stable voltages with this LDO TPS79930YZUT linear regulator from Texas Instruments. Its typical dropout voltage at current is 0.1@200mA V. It has an overall accuracy of ±1 %. This voltage regulation device's single output can produce a current up to 0.2 A. Use this part at voltages between 2.7 V and 6.5 V. With a fixed output that has a voltage of 3 V, this is power management at its best. Maintain a constant voltage level with a load regulation of 0.002%/mA(Typ) and line regulation of 0.02%/V(Typ). This product will be shipped in tape and reel packaging so that components can be mounted effectively. Its polarity is positive. This voltage regulation device has a minimum operating temperature of -40 °C and a maximum of 85 °C. The maximum dropout voltage is 0.175@200mA V.

254 parts: Ships in 2 days

    Total$0.41Price for 1

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2214+
      Manufacturer Lead Time:
      12 weeks
      Minimum Of :
      1
      Maximum Of:
      249
      Country Of origin:
      Philippines
         
      • Price: $0.4104
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2214+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      Philippines
      • In Stock: 4 parts
      • Price: $0.4104
    • (250)

      Ships in 2 days

      Increment:
      250
      Ships from:
      United States of America
      Date Code:
      2214+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      Philippines
      • In Stock: 250 parts
      • Price: $0.4063

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.